MCW	O	O
1868689	O	O
RIGHT	O	O
LUNG	O	O
MASS	O	O
CT	O	O
THORAX	O	O
CT	O	O
EXAMINATION	O	O
OF	O	O
THE	O	O
CHEST	O	O
WAS	O	O
PERFORMED	O	O
FOLLOWING	O	O
INTRAVENOUS	O	O
CONTRAST	O	O
ADMINISTRATION	O	O
,	O	O
WITH	O	O
HELICAL	O	O
IMAGING	O	O
FROM	O	O
THE	O	O
LUNG	O	O
APICES	O	O
THROUGH	O	O
THE	O	O
LUNG	O	O
BASES	O	O
.	O	O
THERE	O	O
ARE	O	O
NO	O	O
OLD	O	O
STUDIES	O	O
AT	O	O
THIS	O	O
INSTITUTION	O	O
FOR	O	O
COMPARISON	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
MASS	1_Red_Minutes	O
IN	O	O
THE	O	O
ANTERIOR	O	O
SEGMENT	O	O
OF	O	1_Red_Minutes
THE	O	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
UPPER	1_Red_Minutes	O
LOBE	1_Red_Minutes	O
CONTAINING	O	O
CENTRAL	O	O
CAVITATION	1_Red_Minutes	O
,	O	O
WHICH	O	O
MEASURES	O	O
APPROXIMATELY	O	O
3.7	O	O
X	O	O
2.3	O	O
CM	O	O
.	O	O
THIS	O	O
ABUTS	O	O
THE	O	O
ANTERIOR	O	O
MEDIASTINUM	O	O
AND	O	O
THE	O	O
ANTERIOR	O	O
CHEST	O	O
WALL	O	O
PLEURA	O	O
.	O	O
THIS	O	O
IS	1_Red_Minutes	O
HIGHLY	1_Red_Minutes	O
SUSPICIOUS	1_Red_Minutes	O
FOR	1_Red_Minutes	O
PRIMARY	1_Red_Minutes	O
CARCINOMA	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
LUNG	1_Red_Minutes	O
.	O	O
THE	O	O
MASS	O	O
APPEARS	O	O
TO	O	O
EXTEND	O	O
CENTRALLY	O	O
ALONG	O	O
THE	O	O
BRONCHOVASCULAR	O	O
BUNDLE	O	O
TO	O	O
THE	O	O
REGION	O	O
OF	O	O
THE	O	O
RIGHT	O	O
HILUM	O	O
.	O	O
THE	O	O
ANTERIOR	O	O
SEGMENT	O	O
RIGHT	O	O
UPPER	O	O
LOBE	O	O
BRONCHUS	O	O
AND	O	O
ITS	O	O
FIRST	O	O
TWO	O	O
BRANCHES	O	O
APPEAR	O	O
NARROWED	O	O
.	O	O
SOFT	O	O
TISSUE	O	O
EXTENDS	O	O
CENTRALLY	O	O
AROUND	O	1_Red_Minutes
THE	O	1_Red_Minutes
RIGHT	O	1_Red_Minutes
UPPER	O	1_Red_Minutes
LOBE	O	1_Red_Minutes
BRONCHUS	O	1_Red_Minutes
.	O	O
ABNORMAL	O	O
SOFT	O	O
TISSUE	O	O
EXTENDS	O	O
TO	O	O
THE	O	O
SUBCARINAL	O	O
REGION	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
NECROTIC	1_Red_Minutes	O
APPEARING	O	O
MASS	1_Red_Minutes	1_Red_Minutes
IN	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
LOWER	1_Red_Minutes	1_Red_Minutes
PARATRACHEAL	1_Red_Minutes	1_Red_Minutes
REGION	1_Red_Minutes	1_Red_Minutes
WITH	O	O
ILL-DEFINED	O	O
MARGINS	O	O
WHICH	O	O
APPEARS	O	O
SOMEWHAT	O	O
SEPARATE	O	O
FROM	O	O
THE	O	O
PRIMARY	O	O
RIGHT	O	O
UPPER	O	O
LOBE	O	O
AND	O	O
RIGHT	O	1_Red_Minutes
HILAR	O	1_Red_Minutes
MASS	O	O
AND	O	O
IS	1_Red_Minutes	O
SUSPICIOUS	1_Red_Minutes	O
FOR	1_Red_Minutes	O
MALIGNANT	1_Red_Minutes	O
LYMPHADENOPATHY	1_Red_Minutes	O
.	O	O
THIS	O	O
MEASURES	O	O
APPROXIMATELY	O	O
3.3	O	O
X	O	O
2.9	O	O
CM	O	O
.	O	O
THERE	O	O
ARE	O	O
SEVERAL	1_Red_Minutes	O
ADDITIONAL	1_Red_Minutes	O
NODES	1_Red_Minutes	O
IN	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
PARATRACHEAL	1_Red_Minutes	O
REGION	1_Red_Minutes	O
,	1_Red_Minutes	O
MOST	1_Red_Minutes	O
OF	1_Red_Minutes	O
WHICH	1_Red_Minutes	O
APPEAR	1_Red_Minutes	O
NECROTIC	1_Red_Minutes	O
.	O	O
LEFT	O	O
LOWER	O	O
PARATRACHEAL	O	O
NODES	O	O
ALL	O	O
ARE	O	O
SMALL	O	O
,	O	O
AS	O	O
IS	O	O
A	O	O
SMALL	O	O
ANTERIOR	O	O
MEDIASTINAL	O	O
LYMPH	O	O
NODE	O	O
.	O	O
THE	O	O
RIGHT	1_Red_Minutes	O
VOCAL	1_Red_Minutes	O
CORD	1_Red_Minutes	O
APPEARS	1_Red_Minutes	O
ADDUCTED	1_Red_Minutes	O
,	1_Red_Minutes	O
RAISING	1_Red_Minutes	O
THE	1_Red_Minutes	O
POSSIBILITY	1_Red_Minutes	O
OF	1_Red_Minutes	O
VOCAL	1_Red_Minutes	O
CORD	1_Red_Minutes	O
PARALYSIS	1_Red_Minutes	O
.	O	O
AT	O	O
LUNG	O	O
WINDOW	O	O
SETTINGS	O	O
,	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
MODERATE	3_Yellow_Days	3_Yellow_Days
CENTRILOBULAR	3_Yellow_Days	3_Yellow_Days
EMPHYSEMA	3_Yellow_Days	3_Yellow_Days
IS	3_Yellow_Days	O
SEEN	3_Yellow_Days	O
.	O	O
MULTIPLE	1_Red_Minutes	3_Yellow_Days
BILATERAL	1_Red_Minutes	3_Yellow_Days
PULMONARY	1_Red_Minutes	3_Yellow_Days
NODULES	1_Red_Minutes	3_Yellow_Days
AND	1_Red_Minutes	3_Yellow_Days
MULTIPLE	1_Red_Minutes	3_Yellow_Days
PLEURAL	1_Red_Minutes	3_Yellow_Days
NODULES	1_Red_Minutes	3_Yellow_Days
ON	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
ARE	O	O
SEEN	O	O
AND	O	O
ARE	O	O
SUSPICIOUS	1_Red_Minutes	O
FOR	1_Red_Minutes	O
METASTATIC	1_Red_Minutes	O
DISEASE	1_Red_Minutes	O
.	O	O
THE	O	O
LARGEST	O	O
OF	O	O
THESE	O	O
IS	O	O
A	O	O
1.5	O	O
X	O	O
1.1	O	O
CM	O	O
NODULE	O	O
IN	O	O
THE	O	O
RIGHT	O	O
MIDDLE	O	O
LOBE	O	O
.	O	O
THERE	O	O
IS	O	O
AN	O	O
EVEN	O	O
LARGER	1_Red_Minutes	O
MASS	1_Red_Minutes	O
OR	1_Red_Minutes	O
MASS-LIKE	1_Red_Minutes	O
AREA	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
CONSOLIDATION	1_Red_Minutes	1_Red_Minutes
IN	1_Red_Minutes	1_Red_Minutes
THE	1_Red_Minutes	1_Red_Minutes
LEFT	1_Red_Minutes	3_Yellow_Days
LOWER	1_Red_Minutes	3_Yellow_Days
LOBE	1_Red_Minutes	3_Yellow_Days
,	1_Red_Minutes	O
WHICH	1_Red_Minutes	O
MAY	1_Red_Minutes	O
BE	1_Red_Minutes	O
INFLAMMATORY	1_Red_Minutes	O
.	O	O
THERE	O	O
ARE	O	O
SCATTERED	O	O
AREAS	O	O
OF	O	O
BRONCHIECTASIS	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
FOCAL	O	O
AREA	O	O
OF	O	O
MUCOUS	O	O
PLUGGING	O	O
IN	O	O
THE	O	O
LEFT	O	O
LOWER	O	O
LOBE	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
TINY	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
PLEURAL	3_Yellow_Days	O
EFFUSION	3_Yellow_Days	O
.	O	O
THE	O	O
ADRENAL	O	O
GLANDS	O	O
APPEAR	O	O
NORMAL	O	O
BILATERALLY	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
LOW	O	O
DENSITY	O	O
LESION	1_Red_Minutes	O
IN	O	O
THE	O	O
POSTERIOR	O	O
SEGMENT	O	O
OF	O	1_Red_Minutes
THE	O	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
OF	O	1_Red_Minutes
THE	O	1_Red_Minutes
LIVER	1_Red_Minutes	1_Red_Minutes
,	O	O
WHICH	O	O
IS	O	O
SUSPICIOUS	1_Red_Minutes	O
FOR	1_Red_Minutes	O
A	1_Red_Minutes	O
HEPATIC	1_Red_Minutes	O
METASTASIS	1_Red_Minutes	O
.	O	O
THIS	O	O
COULD	1_Red_Minutes	O
BE	1_Red_Minutes	O
FURTHER	1_Red_Minutes	O
CHARACTERIZED	1_Red_Minutes	O
WITH	1_Red_Minutes	O
DEDICATED	1_Red_Minutes	O
CT	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
ABDOMEN	1_Red_Minutes	O
AND	1_Red_Minutes	O
PELVIS	1_Red_Minutes	O
.	O	O
ADDITIONAL	3_Yellow_Days	O
QUESTIONABLE	3_Yellow_Days	O
LESIONS	3_Yellow_Days	O
ARE	3_Yellow_Days	O
SEEN	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
LEFT	3_Yellow_Days	O
LOBE	3_Yellow_Days	O
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
LIVER	3_Yellow_Days	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
SMALL	O	O
SPLENULE	O	O
.	O	O
THE	O	O
VISUALIZED	O	O
PORTIONS	O	O
OF	O	O
THE	O	O
KIDNEYS	O	O
AND	O	O
PANCREAS	O	O
ARE	O	O
UNREMARKABLE	O	O
.	O	O
DEGENERATIVE	O	O
CHANGES	O	O
ARE	O	O
SEEN	O	O
IN	O	O
THE	O	O
THORACIC	O	O
SPINE	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
OSSEOUS	O	O
METASTASES	O	O
.	O	O
1	O	O
.	O	O
RIGHT	1_Red_Minutes	1_Red_Minutes
UPPER	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
MASS	1_Red_Minutes	1_Red_Minutes
HIGHLY	1_Red_Minutes	1_Red_Minutes
SUSPICIOUS	1_Red_Minutes	1_Red_Minutes
FOR	1_Red_Minutes	1_Red_Minutes
PRIMARY	1_Red_Minutes	3_Yellow_Days
CARCINOMA	1_Red_Minutes	3_Yellow_Days
OF	O	3_Yellow_Days
THE	O	3_Yellow_Days
LUNG	O	3_Yellow_Days
,	O	O
WITH	O	O
ASSOCIATED	O	O
EXTENSION	O	O
TO	O	O
THE	O	O
REGION	O	O
OF	O	O
THE	O	O
RIGHT	O	O
HILUM	O	O
,	O	O
NARROWING	O	O
OF	O	O
THE	O	O
RIGHT	O	O
ANTERIOR	O	O
SEGMENTAL	O	O
BRONCHUS	O	O
,	O	O
SOFT	O	O
TISSUE	O	O
EXTENSION	O	O
INTO	O	O
THE	O	O
MEDIASTINUM	O	O
AND	O	O
INTO	O	O
THE	O	O
SUBCARINAL	O	O
REGION	O	O
,	O	O
AND	O	O
A	O	O
RIGHT	1_Red_Minutes	O
PARATRACHEAL	1_Red_Minutes	O
NECROTIC	1_Red_Minutes	O
APPEARING	1_Red_Minutes	O
MASS.	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
ADDUCTION	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	1_Red_Minutes
FOCAL	1_Red_Minutes	1_Red_Minutes
CORD	1_Red_Minutes	1_Red_Minutes
RAISING	1_Red_Minutes	O
THE	1_Red_Minutes	O
POSSIBILITY	1_Red_Minutes	1_Red_Minutes
OF	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
FOCAL	1_Red_Minutes	1_Red_Minutes
CORD	1_Red_Minutes	1_Red_Minutes
PARALYSIS	1_Red_Minutes	1_Red_Minutes
.	O	O
2	O	O
.	O	O
SCATTERED	1_Red_Minutes	O
BILATERAL	1_Red_Minutes	O
PULMONARY	1_Red_Minutes	O
AND	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
PLEURAL	1_Red_Minutes	O
NODULES	1_Red_Minutes	O
SUSPICIOUS	1_Red_Minutes	O
FOR	1_Red_Minutes	O
A	1_Red_Minutes	O
METASTASES	1_Red_Minutes	O
.	O	O
3	O	O
.	O	O
AT	1_Red_Minutes	O
LEAST	1_Red_Minutes	O
ONE	1_Red_Minutes	O
HEPATIC	1_Red_Minutes	O
LESION	1_Red_Minutes	O
SUSPICIOUS	1_Red_Minutes	O
FOR	1_Red_Minutes	O
METASTASIS	1_Red_Minutes	3_Yellow_Days
.	O	O
4	O	O
.	O	O
CENTRILOBULAR	3_Yellow_Days	3_Yellow_Days
EMPHYSEMA	3_Yellow_Days	3_Yellow_Days
.	O	O
39313949	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
Thorax	O	O
with	O	O
intravenous	O	O
contrast	O	O
,	O	O
10/25/2009	O	O
Clinical	O	O
History	O	O
:	O	O
High-grade	O	O
serous	O	O
carcinoma	O	O
of	O	O
the	O	O
ovary	O	O
,	O	O
evaluate	O	O
disease	O	O
status	O	O
.	O	O
Comparison	O	O
:	O	O
08/11/2009	O	O
.	O	O
Findings	O	O
:	O	O
A	O	O
subcentimeter	3_Yellow_Days	O
pulmonary	3_Yellow_Days	O
nodule	3_Yellow_Days	O
in	O	O
the	O	O
left	3_Yellow_Days	3_Yellow_Days
upper	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
,	O	O
in	O	O
the	O	O
right	3_Yellow_Days	O
middle	3_Yellow_Days	O
lobe	3_Yellow_Days	O
near	O	O
the	O	O
horizontal	O	O
fissure	O	O
and	O	O
in	O	O
the	O	O
right	3_Yellow_Days	3_Yellow_Days
lower	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
-LRB-	O	O
series	O	O
4	O	O
,	O	O
image	O	O
33	O	O
,	O	O
52	O	O
and	O	O
79	O	O
-RRB-	O	O
remain	3_Yellow_Days	O
unchanged	3_Yellow_Days	3_Yellow_Days
since	O	O
06/25/2008	O	O
.	O	O
They	O	O
are	O	O
indeterminate	3_Yellow_Days	O
and	O	O
can	3_Yellow_Days	O
be	3_Yellow_Days	O
followed	3_Yellow_Days	O
for	3_Yellow_Days	O
a	3_Yellow_Days	O
total	3_Yellow_Days	O
of	3_Yellow_Days	O
2	3_Yellow_Days	O
years	3_Yellow_Days	O
to	3_Yellow_Days	O
determine	3_Yellow_Days	O
stability	3_Yellow_Days	O
.	O	O
Elsewhere	O	O
,	O	O
nodular	O	O
thickening	O	O
along	O	O
the	O	O
major	O	O
fissures	O	O
remain	O	O
unchanged	O	3_Yellow_Days
.	O	O
Minimal	O	3_Yellow_Days
dependent	O	3_Yellow_Days
pleural	O	3_Yellow_Days
thickening	O	3_Yellow_Days
in	O	O
the	O	O
left	O	3_Yellow_Days
lower	O	3_Yellow_Days
lobe	O	3_Yellow_Days
is	O	3_Yellow_Days
overall	O	3_Yellow_Days
unchanged	O	3_Yellow_Days
.	O	O
There	O	O
is	O	O
otherwise	O	O
,	O	O
no	O	O
pleural	O	O
effusions	O	O
.	O	O
No	O	O
abnormally	O	O
enlarged	O	O
lymph	O	O
nodes	O	O
lie	O	O
within	O	O
the	O	O
thorax	O	O
.	O	O
Osseous	O	O
metastasis	O	O
is	O	O
absent	O	O
.	O	O
The	O	O
tip	O	O
of	O	O
a	O	O
right	O	O
port	O	O
catheter	O	O
lies	O	O
in	O	O
the	O	O
SVC	O	O
.	O	O
IMPRESSION	O	O
:	O	O
A	3_Yellow_Days	O
few	3_Yellow_Days	3_Yellow_Days
indeterminate	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
nodules	3_Yellow_Days	3_Yellow_Days
remain	3_Yellow_Days	3_Yellow_Days
stable	3_Yellow_Days	3_Yellow_Days
and	O	3_Yellow_Days
can	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
followed	3_Yellow_Days	3_Yellow_Days
for	3_Yellow_Days	3_Yellow_Days
a	3_Yellow_Days	3_Yellow_Days
total	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
2	3_Yellow_Days	O
years	3_Yellow_Days	O
to	3_Yellow_Days	O
determine	3_Yellow_Days	O
stability	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
otherwise	O	O
,	O	O
no	O	O
obvious	O	O
metastatic	O	O
disease	O	O
to	O	O
the	O	O
thorax	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
71250	O	O
CT	O	O
CHEST	O	O
wo	O	O
CT	O	O
05/05/2007	O	O
Contrast	O	O
enhanced	O	O
CT	O	O
of	O	O
the	O	O
chest	O	O
with	O	O
comparison	O	O
to	O	O
recent	O	O
PE	O	O
study	O	O
of	O	O
4/30/07	O	O
.	O	O
Exam	O	O
is	O	O
read	O	O
in	O	O
conjunction	O	O
with	O	O
the	O	O
Indium-111	O	O
labeled	O	O
white	O	O
blood	O	O
cell	O	O
study	O	O
of	O	O
5/4/07	O	O
.	O	O
Degenerative	O	O
arthritis	O	O
with	O	O
vacuum	O	O
phenonomen	O	O
in	O	O
the	O	O
mid	O	O
thoracic	O	O
spine	O	O
.	O	O
Thoracic	O	O
kyphosis	O	O
.	O	O
Compression	3_Yellow_Days	O
fractures	3_Yellow_Days	O
of	3_Yellow_Days	O
T4-T7	3_Yellow_Days	O
vertebral	3_Yellow_Days	O
bodies	3_Yellow_Days	O
.	O	O
Also	O	O
mild	3_Yellow_Days	O
compression	3_Yellow_Days	O
L1	3_Yellow_Days	O
.	O	O
No	O	O
evidence	O	O
of	O	O
posterior	O	O
mediastinal	O	O
mass	O	O
or	O	O
abscess	O	O
.	O	O
MRI	O	O
would	O	O
be	O	O
more	O	O
sensitive	O	O
in	O	O
further	O	O
evaluation	O	O
for	O	O
discitis/osteomyelitis	O	O
.	O	O
Slight	3_Yellow_Days	O
interval	3_Yellow_Days	O
increase	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
bilateral	3_Yellow_Days	3_Yellow_Days
pleural	3_Yellow_Days	3_Yellow_Days
effusions	3_Yellow_Days	3_Yellow_Days
since	O	O
the	O	O
PE	O	O
study	O	O
of	O	O
4/30/07	O	O
.	O	O
Associated	O	O
compressive	O	O
atelectasis/infiltrates	O	O
.	O	O
New	3_Yellow_Days	O
,	3_Yellow_Days	O
hazy	3_Yellow_Days	O
infiltrate	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	O
upper	3_Yellow_Days	O
lung	3_Yellow_Days	O
anteriorly	3_Yellow_Days	O
.	O	O
Otherwise	O	O
no	O	O
significant	O	O
change	O	O
from	O	O
previous	O	O
.	O	O
Small	3_Yellow_Days	O
pericardial	3_Yellow_Days	O
effusion	3_Yellow_Days	O
or	3_Yellow_Days	O
thickening	3_Yellow_Days	O
.	O	O
Aortic	O	O
calcification	O	O
.	O	O
Cholelithiasis	O	O
.	O	O
Cortical	O	O
scarring	O	O
both	O	O
kidneys	O	O
.	O	O
Watchman	O	O
device	O	O
in	O	O
the	O	O
left	O	O
atrial	O	O
appendage	O	O
with	O	O
thrombus	O	O
.	O	O
Fatty	O	O
atrophy	O	O
of	O	O
the	O	O
pancreas	O	O
.	O	O
37817795	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
Chest	O	O
,	O	O
09/08/2008	O	O
.	O	O
Clinical	O	O
History	O	O
:	O	O
Fibrous	O	O
histiocytoma	O	O
.	O	O
Evaluate	O	O
for	O	O
metastases	O	O
.	O	O
Findings	O	O
:	O	O
As	O	O
noted	O	O
,	O	O
there	O	O
are	O	O
posttreatment	O	O
changes	O	O
in	O	O
both	O	3_Yellow_Days
lungs	O	3_Yellow_Days
and	O	O
pleural	O	O
and	O	O
parenchymal	O	O
features	O	O
with	O	O
the	O	O
most	O	O
noted	O	O
in	O	O
the	O	O
left	O	O
lateral	O	O
posterior	O	O
chest	O	O
wall	O	O
.	O	O
This	O	O
area	O	O
does	O	O
have	O	O
some	O	O
pleural	O	O
and	O	O
reactive	O	O
changes	O	O
.	O	O
Many	O	O
sites	O	O
have	O	O
been	O	O
present	O	O
for	O	O
some	O	O
time	O	O
;	O	O
however	O	O
,	O	O
there	O	O
is	O	O
one	3_Yellow_Days	O
focal	3_Yellow_Days	O
area	3_Yellow_Days	O
that	3_Yellow_Days	O
is	3_Yellow_Days	O
a	3_Yellow_Days	O
little	3_Yellow_Days	O
bit	3_Yellow_Days	O
more	3_Yellow_Days	O
prominent	3_Yellow_Days	O
than	3_Yellow_Days	O
the	3_Yellow_Days	O
other	3_Yellow_Days	O
.	O	O
This	3_Yellow_Days	O
is	3_Yellow_Days	O
indeterminate	3_Yellow_Days	O
at	O	O
this	O	O
time	O	O
and	O	O
suggest	O	O
continued	3_Yellow_Days	O
evaluation	3_Yellow_Days	O
on	O	O
routine	O	O
fashion	O	O
or	O	O
if	O	O
any	O	O
clinical	O	O
findings	O	O
at	O	O
this	O	O
site	O	O
,	O	O
followup	3_Yellow_Days	O
intervention	3_Yellow_Days	O
with	3_Yellow_Days	O
MRI	3_Yellow_Days	O
may	3_Yellow_Days	O
be	3_Yellow_Days	O
helpful	3_Yellow_Days	O
.	O	O
However	O	O
,	O	O
these	O	O
findings	O	O
on	O	O
the	O	O
CT	O	O
are	O	O
indeterminate	O	O
.	O	O
No	O	O
evidence	O	O
of	O	O
new	O	O
parenchymal	O	O
pulmonary	O	O
nodules	O	O
,	O	O
and	O	O
the	O	O
intrathoracic	O	O
opacities	O	O
are	O	O
similar	O	O
to	O	O
prior	O	O
studies	O	O
of	O	O
01/07/2008	O	O
.	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
Bilateral	O	3_Yellow_Days
pleural	O	3_Yellow_Days
and	O	O
parenchymal	O	O
posttreatment	O	O
changes	O	O
with	O	O
the	O	O
most	O	O
noted	O	O
feature	O	O
being	O	O
the	O	O
posterior	O	O
lateral	O	O
aspect	O	O
of	O	O
the	O	O
left	O	O
chest	O	O
wall	O	O
with	O	O
rib	O	O
resection	O	O
and	O	O
soft	O	1_Red_Minutes
tissue	O	1_Red_Minutes
prominence	O	1_Red_Minutes
as	O	O
well	O	O
as	O	O
pleural	O	O
reactive	O	O
change	O	O
.	O	O
On	O	O
image	O	O
54	O	O
series	O	O
2	O	O
,	O	O
this	O	O
is	O	O
more	O	O
prominent	3_Yellow_Days	1_Red_Minutes
chest	3_Yellow_Days	1_Red_Minutes
wall	3_Yellow_Days	1_Red_Minutes
soft	3_Yellow_Days	1_Red_Minutes
tissues	3_Yellow_Days	1_Red_Minutes
in	O	O
the	O	O
subpleural	O	O
space	O	O
compared	O	O
to	O	O
01/07/2008	O	O
;	O	O
however	O	O
,	O	O
this	O	O
has	O	O
varied	O	O
and	O	O
was	O	O
prominent	O	O
on	O	O
the	O	O
prior	O	O
study	O	O
of	O	O
05/14/2007	O	O
as	O	O
well	O	O
,	O	O
and	O	O
suggest	3_Yellow_Days	O
clinical	3_Yellow_Days	O
correlation	3_Yellow_Days	O
to	O	O
see	O	O
if	O	O
there	O	O
are	O	O
any	O	O
signs	O	O
of	O	O
symptoms	O	O
of	O	O
disease	O	O
at	O	O
this	O	O
site	O	O
.	O	O
If	O	O
so	O	O
,	O	O
MRI	3_Yellow_Days	O
of	3_Yellow_Days	O
the	3_Yellow_Days	O
chest	3_Yellow_Days	O
wall	3_Yellow_Days	O
might	O	O
be	O	O
more	O	O
helpful	3_Yellow_Days	O
in	3_Yellow_Days	O
demonstrating	3_Yellow_Days	O
any	3_Yellow_Days	O
reactive	3_Yellow_Days	O
or	3_Yellow_Days	O
new	3_Yellow_Days	O
changes	3_Yellow_Days	O
.	O	O
However	O	O
,	O	O
at	O	O
this	O	O
time	O	O
,	O	O
these	O	O
features	O	O
are	O	O
fairly	O	O
consistent	O	O
with	O	O
posttreatment	O	O
changes	O	O
.	O	O
No	O	O
evidence	O	O
of	O	O
gross	O	O
or	O	O
new	O	O
disease	O	O
.	O	O
2	O	O
.	O	O
There	O	O
is	O	O
changes	O	O
in	O	O
the	O	O
left	O	O
shoulder	O	O
and	O	O
left	O	O
chest	O	O
wall	O	O
and	O	O
upper	O	O
arm	O	O
consistent	O	O
with	O	O
underlying	O	O
osteopenia	O	O
most	O	O
likely	O	O
related	O	O
to	O	O
the	O	O
prior	O	O
intervention	O	O
treatment	O	O
with	O	O
some	O	O
dysfunction	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MEDIASTINUM	O	O
PLEURA	O	O

